207 related articles for article (PubMed ID: 32389535)
1. Immune Modulation of Monocytes Dampens the IL-17
Pinget GV; Tan J; Niewold P; Mazur E; Angelatos AS; King NJC; Macia L
J Invest Dermatol; 2020 Dec; 140(12):2398-2407.e1. PubMed ID: 32389535
[TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model.
Choi CW; Kim BR; Yang S; Kim Y; Kang JS; Youn SW
J Dermatol Sci; 2020 Jun; 98(3):199-202. PubMed ID: 32451152
[No Abstract] [Full Text] [Related]
6. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
7. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation.
Matsumoto R; Dainichi T; Tsuchiya S; Nomura T; Kitoh A; Hayden MS; Ishii KJ; Tanaka M; Honda T; Egawa G; Otsuka A; Nakajima S; Sakurai K; Nakano Y; Kobayashi T; Sugimoto Y; Kabashima K
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089718
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.
Shi Z; Wu X; Yu S; Huynh M; Jena PK; Nguyen M; Wan YY; Hwang ST
J Invest Dermatol; 2020 Sep; 140(9):1815-1823. PubMed ID: 32057839
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Chen Y; Yan Y; Liu H; Qiu F; Liang CL; Zhang Q; Huang RY; Han L; Lu C; Dai Z
Theranostics; 2020; 10(23):10466-10482. PubMed ID: 32929360
[TBL] [Abstract][Full Text] [Related]
12. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
[TBL] [Abstract][Full Text] [Related]
13. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
14. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
[TBL] [Abstract][Full Text] [Related]
15. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
[TBL] [Abstract][Full Text] [Related]
16. Intermittent fasting alleviates IMQ-induced psoriasis-like dermatitis via reduced γδT17 and monocytes in mice.
Chen X; Fu C; Zheng Y; Li X; Liao Y; Zheng Y; Liang W; Zhao Y; Huang J; Huang T; Bu J; Shen E
Arch Dermatol Res; 2024 May; 316(5):176. PubMed ID: 38758283
[TBL] [Abstract][Full Text] [Related]
17. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
18. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]